Publications - IR Sant Pau

Search

01/04/2026 Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study)

Monge, A, Martinez-De las Fuentes, AM, Burgos, J, Pou, C, Lakhani, JS, Navarro, A, Castanon, RA, Garcia-Urrestarazu, EJ, Sayés, A, Alcaide, AB, Erro, M, Moreno, BR, Sánchez-Cucó, A, Santisteve, S, Benitez, ID, Moncusi-Moix, A, Gracia-Lavedan, E, Manzano, C, Morales, A, Barbé, F, Suarez-Cuartin, G, de la Rosa-Carrillo, D, de-Torres, JP, González, J. Combining Airway Clearance Techniques and Inhaled Antibiotics in Chronic Bronchial Infection: Real-World Evidence of Exacerbation Reduction (INBREATHING Study). ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(4)DOI:10.1016/j.arbres.2025.10.017. PMID:41253672. IF:9.200(Q1/1D).

01/02/2026 LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY

Lázaro, AR, Mediano, O, Cano, I, Egea, C, Monasterio, M, Muñoz, C, Podzamczer, I, Gonzalez, M, Grau, N, Cabriada, V, Cano, MDP, Dalmases, M, Salord, N, Castelló, C, Ramos, A, Lores, V, Arias, B, Jara, B, Ruiz, C, Horrillo, A, Romero, S, Pozuelo, L, Martinez, D, Boukichou, N, Barbé, F, de la Torre, MS. LONG-TERM CLINICAL AND FUNCTIONAL EVOLUTION IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND DAYTIME SLEEPINESS TREATED WITH CPAP: RESULTS FROM THE HYPNOSA COHORT STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).

01/01/2026 Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study

Gessner, C, Russell, REK, Greulich, T, Lommatzsch, M, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Kupczyk, M, Braido, F, Piraino, A, Scaffidi-Argentina, U, Bogoevska, V, Trinkmann, F. Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study. Journal of Asthma and Allergy. 2026; 19DOI:10.2147/JAA.S582286. PMID:41767174. IF:3.000(Q2/4D).

01/03/2026 REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE

Harniman, K, Gessner, C, Bogoevska, V, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Fritz, C, Hahn, A, Trinkmann, F. REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE. INTERNAL MEDICINE JOURNAL. 2026; 56DOI:. PMID:. IF:1.500(Q2/5D).

13/04/2026 Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis

Blanco, R, Rua-Figueroa, I, Blanco-Aparicio, M, Casafont-Solé, I, Espígol-Frigolé, G, García-Moguel, I, Plaza, V, Soto-Campos, G. Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis. Frontiers in Immunology. 2026; 17DOI:10.3389/fimmu.2026.1785849. PMID:42051495. IF:5.900(Q1/2D).

01/07/2025 FEV1Q as a Predictive Metric for Asthma Outcomes

Betancor, D, Olaguibel, JM, del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cardaba, B, Cañas, JA, Domínguez-Ortega, J, Cruz, MJ, Curto, E, Garcia de la Fuente, A, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza, V, Quirce, S, Rial, MJ, Soto-Retes, L, Valverde-Monge, M, Mahíllo-Fernández, I, Sastre, J. FEV1Q as a Predictive Metric for Asthma Outcomes. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(7)DOI:10.1016/j.arbres.2025.02.011. PMID:40087119. IF:9.200(Q1/1D).

01/03/2026 SEPAR Recommendations on Vaccination for Chronic Respiratory Patients

de Miguel-Díez, J, Torres-Castro, R, Herrero, FS, Villanueva, RM, Gómez, BS, Fernández, SQ, Rojo, RP, Cuesta, VMM, Castillo, ME, Fernández, LS, Martínez, MMC, Mediano, O, García-Ortega, A, Rivero, JLG, de la Rosa-Carrillo, D. SEPAR Recommendations on Vaccination for Chronic Respiratory Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(3)DOI:10.1016/j.arbres.2025.06.005. PMID:40592680. IF:9.200(Q1/1D).

01/07/2025 Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).

Almonacid C, Blanco M, Ferreira J, García G, Morete A, Quirce S, Soto-Campos G, Plaza V. Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).. Open Respiratory Archives. 2025; 7(3)DOI:10.1016/j.opresp.2025.100453. PMID:40677934. IF:(Q/D).

01/11/2025 Clinical practice guide for nurses that optimizes nurse's comprehensive care of patients undergoing immunotherapy

Serra-Lopez, J, Miranda, A, Soria, A, Lopez, N, Castañon, E, Majem, M. Clinical practice guide for nurses that optimizes nurse's comprehensive care of patients undergoing immunotherapy. Enfermeria Clinica. 2025; 35(6)DOI:10.1016/j.enfcle.2025.502193. PMID:40204238. IF:(Q/D).

01/08/2023 Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles

Martinez-Torro, C, Alba-Castellon, L, Carrasco-Diaz, LI, Serna, N, Imedio, L, Gallardo, A, Casanova, I, Unzueta, U, Vazquez, E, Mangues, R, Villaverde, A. Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 164DOI:10.1016/j.biopha.2023.114976. PMID:37276641. IF:6.900(Q1/1D).

29/04/2026 Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD

Fonseca-Santos, M, Puertas, B, Arzuaga-Méndez, J, Ancin-Arteaga, I, Castaño-Diez, S, De Miguel, C, Canet-Maldonado, M, Bosch-Schips, M, Palomo-Rumschisky, P, Blanco, ML, Gil-Alós, D, Moreno-Igoa, M, Santa-Catalina, PG, Azibeiro, R, Puerta, C, Mesa-Tudela, A, López-Cadenas, F, Tuset, E, Fiallo-Suarez, DV, Ramos, F, Gimenez, MT, Peri, V, Mayani, K, Montañes-García, MA, Villalba, A, Rivas, JMH, Díaz-Beyá, M, Díez-Campelo, M. Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD. Frontiers in Immunology. 2026; 17DOI:10.3389/fimmu.2026.1743509. PMID:42136657. IF:5.900(Q1/2D).

01/03/2026 Interpretable Artificial Intelligence Model for the Automatic Identification of Botryoid Neutrophils

Merino, A, Barrera, K, Verdú, G, San José, P, Vallbé, M, Molina, A, Rodellar, J. Interpretable Artificial Intelligence Model for the Automatic Identification of Botryoid Neutrophils. International Journal of Laboratory Hematology. 2026; 48DOI:. PMID:. IF:2.300(Q2/5D).

01/06/2023 Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquén A, Briones J, Caballero AC, Campos A, Español I, Ferra C, López SG, González Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jiménez-Ubieto A, Kwon M, Corral LL, López-Godino O, Munoz MCM, Martínez-Cibrián N, Gómez JM, Pérez-Ortega L, Ortí G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yáñez L, Varela R, Echechipia IC, Caballero D, Sureda A. Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.. BONE MARROW TRANSPLANTATION. 2023; 58(6)DOI:10.1038/s41409-023-01967-9. PMID:37076611. IF:(Q/D).

01/04/2026 Influence of the level of education on cognitive function in Parkinson's disease

Santos-García, D, Fonticoba, TD, Bartolomé, CC, Alvarado, MCI, Samaniego, L, Maside, AL, Gallego, L, Barreiro, LC, Caramés, JR, Painceiras, MJF, González, JMP, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Pareés, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordás, C, Menéndez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P. Influence of the level of education on cognitive function in Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2026; 133(4)DOI:10.1007/s00702-025-03074-z. PMID:41428073. IF:4.000(Q1/2D).

17/10/2025 Perceptions of neuromuscular electrostimulation of patients with Parkinson's disease and their caregivers: the impact on swallowing and speech from a qualitative perspective

Simao, MD, Poveda-Moral, S, Daniel, ER, Ganora, AD, Vargas, MV, Kulisevsky, J. Perceptions of neuromuscular electrostimulation of patients with Parkinson's disease and their caregivers: the impact on swallowing and speech from a qualitative perspective. Journal Of Patient-Reported Outcomes. 2025; 9(1)DOI:10.1186/s41687-025-00931-z. PMID:41105286. IF:(Q/D).

19/02/2026 Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study

Luquin, M, Lopez-Ariztegui, N, Castrillo, JCM, Manzanares, LL, Bataller, IS, Fernández, AK, Pastor, BV, Vila, BS, Sauco, MA, Mora, JP, González, JMA, Ruiz-Espiga, PJG, de Fàbregues, O, del Val, JL, Arillo, VC, Moreno, C, Ameijeiras, JB, Jiménez, IP, Ayuela, IT. Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study. Frontiers in Neurology. 2026; 17DOI:10.3389/fneur.2026.1738500. PMID:41798821. IF:2.800(Q2/5D).

02/01/2026 Validation of the Spanish version of the cerebellar cognitive-affective syndrome scale

Serrano-Munuera, C, Martínez-Regueiro, R, Fernández, EMM, Perna, BA, Domínguez, DL, Rojas-Bartolomé, L, Gómez, AA, Torre, PP, Abildúa, MJA, Axpe, IR, Feria-Vilar, I, Pérez, JP, Schmahmann, JD, García-Sánchez, C. Validation of the Spanish version of the cerebellar cognitive-affective syndrome scale. CLINICAL NEUROPSYCHOLOGIST. 2026; 40(1)DOI:10.1080/13854046.2025.2488453. PMID:40260849. IF:2.700(Q2/3D).

01/12/2025 A Real-World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms

Stocchi, F, Kulisevsky, J, Jost, WH. A Real-World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms. Movement Disorders Clinical Practice. 2025; 12(12)DOI:10.1002/mdc3.70188. PMID:40545913. IF:2.700(Q2/5D).

01/01/2025 Volume alterations of the hippocampus and amygdala in patients with schizophrenia and persistent auditory hallucinations.

Perez-Rando M., Penades-Gomiz C., Martinez-Marin P., García-Martí G., Aguilar E.J., Escarti M.J., Grasa E., Corripio I., Sanjuan J., Nacher J.. Volume alterations of the hippocampus and amygdala in patients with schizophrenia and persistent auditory hallucinations.. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(4)DOI:10.1016/j.rpsm.2023.05.002. PMID:37495479. IF:(Q/D).

04/07/2024 Spanish experts consensus on emergency psychiatric care in hospital emergency departments

Gordillo-Urbano, RM, Crespo-Facorro, B, Pérez-Solá, V, Cardoner, N, García-Ligero, E, Moreno, C, Ramos-Quiroga, JA, Ruiz-Veguilla, M, Vázquez-Vallejo, M, Prados-Ojeda, JL. Spanish experts consensus on emergency psychiatric care in hospital emergency departments. BMC Psychiatry. 2024; 24(1)DOI:10.1186/s12888-024-05939-1. PMID:38965477. IF:3.600(Q1/3D).

01/01/2022 State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease

Hampel, H, Shaw, LM, Aisen, P, Chen, C, Lleo, A, Iwatsubo, T, Iwata, A, Yamada, M, Ikeuchi, T, Jia, JP, Wang, HL, Teunissen, CE, Peskind, E, Blennow, K, Cummings, J, Vergallo, A. State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2022; 18(1)DOI:10.1002/alz.12372. PMID:34043269. IF:14.000(Q1/1D).

01/08/2021 Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve

Illan-Gala, I, Casaletto, KB, Borrego-Ecija, S, Arenaza-Urquijo, EM, Wolf, A, Cobigo, Y, Goh, SYM, Staffaroni, AM, Alcolea, D, Fortea, J, Blesa, R, Clarimon, J, Iulita, MF, Brugulat-Serrat, A, Llado, A, Grinberg, LT, Possin, K, Rankin, KP, Kramer, JH, Rabinovici, GD, Boxer, A, Seeley, WW, Sturm, VE, Gorno-Tempini, ML, Miller, BL, Sanchez-Valle, R, Perry, DC, Lleo, A, Rosen, HJ. Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve. ALZHEIMERS & DEMENTIA. 2021; 17(8)DOI:10.1002/alz.12299. PMID:33590953. IF:16.655(Q1/1D).

01/11/2022 New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia

del Campo, M, Zetterberg, H, Gandy, S, Onyike, CU, Oliveira, F, Udeh-Momoh, C, Lleo, A, Teunissen, CE, Pijnenburg, Y. New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2022; 18(11)DOI:10.1002/alz.12643. PMID:35235699. IF:14.000(Q1/1D).

01/07/2024 Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview

Badhwar, A, Hirschberg, Y, Valle-Tamayo, N, Iulita, MF, Udeh-Momoh, CT, Matton, A, Tarawneh, RM, Rissman, RA, Ledreux, A, Winston, CN, Haqqani, AS. Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview. ALZHEIMERS & DEMENTIA. 2024; 20(7)DOI:10.1002/alz.13823. PMID:38864416. IF:11.100(Q1/1D).

11/04/2023 Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome

Videla L., Benejam B., Carmona-Iragui M., Barroeta I., Fernández S., Arranz J., Azzahchi S.E., Altuna M., Padilla C., Valldeneu S., Pegueroles J., Montal V., Aranha M.R., Vaqué-Alcázar L., Iulita M.F., Alcolea D., Bejanin A., Videla S., Blesa R., Lleó A., Fortea J.. Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2023; 19(9)DOI:10.1002/alz.13073. PMID:37038748. IF:13.100(Q1/1D).

06/04/2023 Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome

Aranha, MR, Iulita M.F., Montal V., Pegueroles J., Bejanin A., Vaqué-Alcázar L., Grothe M.J., Carmona-Iragui M., Videla L., Benejam B., Arranz J., Padilla C., Valldeneu S., Barroeta I., Altuna M., Fernández S., Ribas L., Valle-Tamayo N., Alcolea D., González-Ortiz S., Bargalló N., Zetterberg H., Blennow K., Blesa R., Wisniewski T., Busciglio J., Cuello A.C., Lleó A., Fortea J.. Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2023; 19(11)DOI:10.1002/alz.12999. PMID:37021589. IF:13.100(Q1/1D).

01/06/2025 Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Barroeta, I, Videla, L, Carmona-Iragui, M, Fortea, J, Rafii, MS. Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70258. PMID:40528298. IF:11.100(Q1/1D).

01/06/2025 Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome

Sauer, M, Gomes, BF, Shahrouki, P, Lantero-Rodriguez, J, Montoliu-Gaya, L, Camporesi, E, Belbin, O, Alcolea, D, Kumar, A, Sharma, M, Singh, S, Brinkmalm, G, Gobom, J, Carmona-Iragui, M, Schöll, M, Janelidze, S, Deep, G, Blennow, K, Zetterberg, H, Brinkmalm, A, Lleó, A, Fortea, J, Hansson, O, Ashton, NJ, Nilsson, J. Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70241. PMID:40522075. IF:11.100(Q1/1D).

01/04/2025 Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum

Valle-Tamayo, N, Aranha, MR, Pérez-González, R, Serrano-Requena, S, Videla, L, Barroeta, I, Benejam, B, Chiva-Blanch, G, Jimenez, A, Busciglio, J, Wisniewski, T, Do Carmo, S, Alvarez-Sánchez, E, Muñoz, L, Bejanin, A, Belbin, O, Alcolea, D, Carmona-Iragui, M, Lleó, A, Cuello, AC, Fortea, J, Dols-Icardo, O, Iulita, MF. Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.70137. PMID:40257051. IF:11.100(Q1/1D).

27/03/2025 Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study

Ivain, P, Baksh, A, Saini, F, Idris, M, Tamayo-Elizalde, M, Wells, J, Benejam, B, Loosli, SV, Sandkühle, K, Wlasich, E, Wagemann, O, Levin, J, Martet, D, Sacco, S, Falquero, S, Clert, M, Rebillat, AS, Khoo, WM, Smith, MA, Beresford-Webb, J, Zaman, S, Carmona-Iragui, M, Videla, L, Fortea, J, Langballe, EM, Medboen, IT, Larsen, FK, Baldimtsi, E, Paradisi, R, Ntailakis, P, Tsolaki, M, Papantoniou, G, Mcglinchey, E, Mccarron, M, Kennelly, S, Strydom, A. Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70071. PMID:40145416. IF:11.100(Q1/1D).

01/10/2024 Blood-based multivariate methylation risk score for cognitive impairment and dementia

Koetsier, J, Cavill, R, Reijnders, R, Harvey, J, Homann, J, Kouhsar, M, Deckers, K, Kohler, S, Eijssen, LMT, van den Hove, DLA, Demuth, I, Düzel, S, Smith, RG, Smith, AR, Burrage, J, Walker, EM, Shireby, G, Hannon, E, Dempster, E, Frayling, T, Mill, J, Dobricic, V, Johannsen, P, Wittig, M, Franke, A, Vandenberghe, R, Schaeverbeke, J, Freund-Levi, Y, Frölich, L, Scheltens, P, Teunissen, CE, Frisoni, G, Blin, O, Richardson, JC, Bordet, R, Engelborghs, S, de Roeck, E, Martinez-Lage, P, Tainta, M, Lleó, A, Sala, I, Popp, J, Peyratout, G, Verhey, F, Tsolaki, M, Andreasson, U, Blennow, K, Zetterberg, H, Streffer, J, Vos, SJB, Lovestone, S, Visser, PJ, Lill, CM, Bertram, L, Lunnon, K, Pishva, E. Blood-based multivariate methylation risk score for cognitive impairment and dementia. ALZHEIMERS & DEMENTIA. 2024; 20(10)DOI:10.1002/alz.14061. PMID:39193899. IF:11.100(Q1/1D).

01/02/2026 A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology

Huber, H, Montoliu-Gaya, L, Brum, WS, Vávra, J, Yakoub, Y, Weninger, H, Braun-Wohlfahrt, LS, Simrén, J, Boada, M, Ruiz, A, Cano, A, Orellana, A, Valero, S, Cañada, L, Tantinya, N, Nogales, AB, Sanz-Cartagena, P, Dittrich, A, Skoog, I, Sander-Long, M, Ballard, C, Richards, M, O'Leary, M, Clemmensen, FK, Wandall, HHD, Altomare, D, Cantoni, V, Stomrud, E, Palmqvist, S, Lleo, A, Alcolea, D, Iragui, MC, Hernandez, AS, Benejam, B, Toro, LV, Singh, A, Denkinger, MN, Simonsen, AH, Kern, S, Corbett, A, Fortea, J, Honigberg, L, Borroni, B, Hansson, O, Morató, X, Blennow, K, Zetterberg, H, Ashton, NJ. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology. NATURE MEDICINE. 2026; 32(2)DOI:10.1038/s41591-025-04080-0. PMID:41491101. IF:50.000(Q1/1D).

01/01/2026 Cortical mean diffusivity detects early age-related changes and associates with cognition and plasma biomarkers

Perera-Cruz, O, Solé-Padullés, C, Mulet-Pons, L, Cabello-Toscano, M, Morse, RM, Abellaneda-Pérez, K, Perellón-Alfonso, R, Cattaneo, G, Solana-Sánchez, J, Alviarez-Schulze, V, Bargalló, N, Fortea, J, Tormos, JM, Pascual-Leone, A, Zetterberg, H, Vaqué-Alcázar, L, Bartrés-Faz, D. Cortical mean diffusivity detects early age-related changes and associates with cognition and plasma biomarkers. Brain Communications. 2026; 8(1)DOI:10.1093/braincomms/fcaf511. PMID:41756214. IF:(Q/D).

01/02/2026 INTERNATIONAL RECOMMENDATIONS FOR SLEEP AND CIRCADIAN RESEARCH IN AGING AND ALZHEIMER'S DISEASE: A DELPHI CONSENSUS STUDY

André, C, Stankeviciute, L, Michaelian, JC, Antonsdottir, IM, Benca, RM, Coulthard, EJ, D'Rozario, AL, Dijk, DJ, Gimenez, S, Gorgoni, M, Leng, Y, Lucey, BP, Pase, MP, Rainey-Smith, SR, Rosenzweig, I, Spira, AP, Winer, JR, Rauchs, G, Naismith, SL. INTERNATIONAL RECOMMENDATIONS FOR SLEEP AND CIRCADIAN RESEARCH IN AGING AND ALZHEIMER'S DISEASE: A DELPHI CONSENSUS STUDY. SLEEP MEDICINE. 2026; 138DOI:. PMID:. IF:3.400(Q2/3D).

19/01/2026 Automated item-level measures of verbal fluency in semantic and logopenic primary progressive aphasia

Vonk, JMJ, Ferrante, FJ, Morin, BT, Rodriguez, DA, Lin, M, Bogley, R, de Leon, J, Tee, BL, Santos-Santos, MA, Miller, ZA, Mandelli, ML, Gorno-Tempini, ML, García, AM. Automated item-level measures of verbal fluency in semantic and logopenic primary progressive aphasia. ALZHEIMERS & DEMENTIA. 2026; 22(1)DOI:10.1002/alz.71124. PMID:41554669. IF:11.100(Q1/1D).

21/11/2025 Apolipoprotein E and Alzheimer's disease pathology in a diverse autopsy study

Suemoto, CK, Paradela, R, Leite, REP, Paes, VR, Pasqualucci, CA, Ferriolli, E, Zatz, M, Santos, GD, de Alexandria, MALS, Pereira, AC, Fortea, J, Naslavsky, M, Grinberg, LT. Apolipoprotein E and Alzheimer's disease pathology in a diverse autopsy study. ALZHEIMERS & DEMENTIA. 2025; 21(11)DOI:10.1002/alz.70927. PMID:41268805. IF:11.100(Q1/1D).

08/01/2026 Novel insights into Alzheimer's disease through the study of individuals with Down syndrome

Head, E, Cohen, A, Fortea, J, McGlinchey, E. Novel insights into Alzheimer's disease through the study of individuals with Down syndrome. ALZHEIMERS & DEMENTIA. 2026; 22(1)DOI:10.1002/alz.71074. PMID:41505228. IF:11.100(Q1/1D).

01/08/2025 Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome

Sánchez-Moreno, B, Zhang, LD, Salaberry, AC, Rozalem-Aranha, M, Moldenhauer, F, Brudfors, M, Ashburner, J, Nachev, P, de Asúa, DR, Strange, BA. Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(8)DOI:10.1002/alz.70296. PMID:40762120. IF:11.100(Q1/1D).

12/11/2025 CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models

Ninou, AH, Caruana, P, Marti, L, Tornero, J, De Llanos, EL, Casas, FC, de la Fuente, N, Aguilar-del Castillo, F, García-Sanchez, C, Cepeda-Franco, C, Padillo-Ruíz, J, Céspedes, MV. CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models. Drug Delivery and Translational Research. 2025; DOI:10.1007/s13346-025-02013-5. PMID:41225246. IF:5.500(Q1/1D).

01/04/2024 Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?

Bebia, V, Díaz-Feijoo, B, Tejerizo, A, Torne, A, Benito, V, Hernández, A, Gorostidi, M, Domingo, S, Bradbury, M, Luna-Guibourg, R, Gil-Moreno, A. Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?. Cancers. 2024; 16(7)DOI:10.3390/cancers16071423. PMID:38611101. IF:4.400(Q2/3D).